Question 1

What does ctDNA monitoring involve, and how will it benefit my treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the ctDNA Monitoring in Early Breast Cancer clinical trial (NCT04353557). Contact the study team or your healthcare provider for specific answers.

Question 2

Am I eligible to participate in this trial based on my current health status?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the ctDNA Monitoring in Early Breast Cancer clinical trial (NCT04353557). Contact the study team or your healthcare provider for specific answers.

Question 3

What kind of tests will I need to undergo during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the ctDNA Monitoring in Early Breast Cancer clinical trial (NCT04353557). Contact the study team or your healthcare provider for specific answers.

Question 4

How will the results of ctDNA monitoring be used to guide my treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the ctDNA Monitoring in Early Breast Cancer clinical trial (NCT04353557). Contact the study team or your healthcare provider for specific answers.

Question 5

What are the potential risks or side effects of participating in this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the ctDNA Monitoring in Early Breast Cancer clinical trial (NCT04353557). Contact the study team or your healthcare provider for specific answers.

Question 6

How often will I need to visit the study site, and what will those visits entail?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the ctDNA Monitoring in Early Breast Cancer clinical trial (NCT04353557). Contact the study team or your healthcare provider for specific answers.

What this study is about